Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Massive haemoptysis: the definition should be revised

W. H. Ibrahim
European Respiratory Journal 2008 32: 1131-1132; DOI: 10.1183/09031936.00080108
W. H. Ibrahim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editors:

Massive haemoptysis represents one of the most challenging conditions in clinical practice. The condition is potentially lethal and, therefore, warrants clear understanding and precise definition. The definition of massive haemoptysis has not been completely agreed upon and varies widely in the literature. It is unfortunate that almost all previous definitions of massive haemoptysis relied only on the volume of expectorated blood. The use of expectorated blood volume alone to define massive haemoptysis is often misleading and confusing for three main reasons. First, no cut-off volume has been agreed upon in the literature. While Amirana et al. 1 proposed an amount of 100 mL of expectorated blood in 24 h to define massive haemoptysis, Corey and Hla 2 defined massive haemoptysis as expectoration of ≥1,000 mL of blood over 24 h. In the middle of the spectrum we find other studies that use 200 mL 3, 240 mL 4, 500 mL 5 or 600 mL 6 as a cut-off volume for the definition of massive haemoptysis. Secondly, in real practice, the quantification of haemoptysis is often difficult and, from a clinical point of view, such criteria are not useful 7. In many instances the amount of expectorated blood may be exaggerated by patients. Furthermore, in a majority of patients, quantification of expectorated blood volume may underestimate the overall amount of blood loss because the volume of blood engulfing the involved lobes or lungs is not quantified and may be significant 8. Thirdly, morbidity and mortality in patients with haemoptysis depend on not only the volume of expectorated blood but also the rate of bleeding, the ability of the patient to clear blood from the airways and the extent and severity of any underlying lung disease 9. The confusion created by the arbitrary use of the volume of expectorated blood to define massive haemoptysis has led other authors to consider the magnitude of effects (namely airway obstruction and hypotension) as the defining factors 10, 11.

I feel that the confusion will persist if we continue to use the word “massive”. The term “massive haemoptysis” is a general term that was originally selected to describe the magnitude of life-threatening bleeding. Over time, this term became a loosely applied descriptor for the condition as the word “massive” necessitates the identification of a specific volume of blood. Therefore, in order to precisely define this serious condition, we should move away from using the word massive. The term “life-threatening haemoptysis” may provide a fascinating and rich understanding of the condition. Thus, life-threatening haemoptysis may be defined as any haemoptysis that: 1) is >100 mL in 24 h; 2) causes abnormal gas exchange/airway obstruction; or 3) causes haemodynamic instability. The cut-off volume of 100 mL per 24 h has been selected because it is the smallest amount of haemoptysis that is reported in literature to threaten the life of the patient.

Statement of interest

None declared.

    • © ERS Journals Ltd

    References

    1. ↵
      Amirana M, Frater R, Tirschwell P, Janis M, Bloomberg A, State D. An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis. Am Rev Respir Dis 1968;97:187–192.
      OpenUrlPubMedWeb of Science
    2. ↵
      Corey R, Hla KM. Major and massive hemoptysis: reassessment of conservative management. Am J Med Sci 1987;294:301–309.
      OpenUrlPubMedWeb of Science
    3. ↵
      Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J Thorac Cardiovasc Surg 1993;105:394–397.
      OpenUrlPubMedWeb of Science
    4. ↵
      Brinson GM, Noone PG, Mauro MA, et al. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med 1998;157:1951–1958.
      OpenUrlPubMedWeb of Science
    5. ↵
      Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997;112:440–444.
      OpenUrlCrossRefPubMedWeb of Science
    6. ↵
      Crocco JA, Rooney JJ, Fankushen DS, DiBenedetto RJ, Lyons HA. Massive hemoptysis. Arch Intern Med 1968;121:495–498.
      OpenUrlCrossRefPubMedWeb of Science
    7. ↵
      Håkanson E, Konstantinov IE, Fransson SG, Svedjeholm R. Management of life-threatening hemoptysis. Br J Anaesth 2002;88:291–295.
      OpenUrlAbstract/FREE Full Text
    8. ↵
      Jean-Batiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000;28:1642–1647.
      OpenUrlCrossRefPubMedWeb of Science
    9. ↵
      Albert RK, Spiro SG, Jett JR, eds. Clinical Respiratory Medicine. 2nd Edn. Philadelphia, Pennsylvania, Mosby 2004; pp. 253–254
    10. ↵
      Dweik RA, Stoller JK. Role of bronchoscopy in massive hemoptysis. Clin Chest Med 1999;20:89–105.
      OpenUrlCrossRefPubMedWeb of Science
    11. ↵
      Garzon AA, Cerruti MM, Golding ME. Exsanguinating hemoptysis. J Thorac Cardiovasc Surg 1982;84:829–833.
      OpenUrlPubMedWeb of Science
    PreviousNext
    Back to top
    View this article with LENS
    Vol 32 Issue 4 Table of Contents
    European Respiratory Journal: 32 (4)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Massive haemoptysis: the definition should be revised
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    Massive haemoptysis: the definition should be revised
    W. H. Ibrahim
    European Respiratory Journal Oct 2008, 32 (4) 1131-1132; DOI: 10.1183/09031936.00080108

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Massive haemoptysis: the definition should be revised
    W. H. Ibrahim
    European Respiratory Journal Oct 2008, 32 (4) 1131-1132; DOI: 10.1183/09031936.00080108
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Extracorporeal life support as a bridge to lung transplantation strategy in anti-MDA5+ rapidly progressive interstitial lung disease is life-saving but with persistent difficulties at the bedside
    • Liver cancer in severe alpha-1 antitrypsin deficiency: Who is at risk?
    • Cancer risk in severe alpha-1-antitrypsin deficiency - the importance of the early identification
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2022 by the European Respiratory Society